Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting ...

Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that can detect traces of tumor circulating in the blood. The core of Tethis’ innovation lies in its integrated ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, which shows real promise in ...

Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.

Breast cancer liquid biopsy industry is projected to witness a CAGR of 22.6% during the period 2024-2032. This growth can be ...

New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...

Oxford Cancer Analytics Raises USD$11M in Series A Funding to Transform Early Lung Cancer Detection and Enable Curative ...